Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Trials
|
May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Trials
|
April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Therapeutic Advances in Psychopharmacology
|
December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial
Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
July 23, 2011
White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder
Frederick Sundram, Quinton Deeley, Sagari Sarkar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors
Rachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Neuropharmacology
|
September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures
Carina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
The Journal of Clinical Psychiatry
|
August 18, 2022
A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder
Joseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Palliative & Supportive Care
|
November 3, 2022
The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey
Lisa M Reynolds, Brian Barnett, Jeremy Weleff, et al.
Artificial Intelligence in Medicine
|
October 25, 2024
Advancing health coaching: A comparative study of large language model and health coaches
Qi Chwen Ong, Chin-Siang Ang, Davidson Zun Yin Chee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 10, 2019
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
Rachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Trials
|
May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Trials
|
April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Therapeutic Advances in Psychopharmacology
|
December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial
Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
July 23, 2011
White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder
Frederick Sundram, Quinton Deeley, Sagari Sarkar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors
Rachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Neuropharmacology
|
September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures
Carina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
The Journal of Clinical Psychiatry
|
August 18, 2022
A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder
Joseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Palliative & Supportive Care
|
November 3, 2022
The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey
Lisa M Reynolds, Brian Barnett, Jeremy Weleff, et al.
Artificial Intelligence in Medicine
|
October 25, 2024
Advancing health coaching: A comparative study of large language model and health coaches
Qi Chwen Ong, Chin-Siang Ang, Davidson Zun Yin Chee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 10, 2019
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
Rachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Page
of 8